| Sodium glucose CoTransporter 2 (SGLT2) inhibitors: Current status and future perspective T Madaan, M Akhtar, AK Najmi European Journal of Pharmaceutical Sciences 93, 244-252, 2016 | 128 | 2016 |
| Lutein, a versatile phyto-nutraceutical: An insight on pharmacology, therapeutic indications, challenges and recent advances in drug delivery T Madaan, AN Choudhary, S Gyenwalee, S Thomas, H Mishra, M Tariq, ... PharmaNutrition 5 (2), 64-75, 2017 | 66 | 2017 |
| Engineered bacteria enhance immunotherapy and targeted therapy through stromal remodeling of tumors SC Thomas, T Madaan, NS Kamble, NA Siddiqui, GM Pauletti, N Kotagiri Advanced healthcare materials 11 (2), 2101487, 2022 | 54 | 2022 |
| Exploring the multifaceted neuroprotective actions of Emblica officinalis (Amla): a review I Husain, S Zameer, T Madaan, A Minhaj, W Ahmad, A Iqubaal, A Ali, ... Metabolic brain disease 34, 957-965, 2019 | 53 | 2019 |
| Tannins Enriched Fraction of Emblica officinalis Fruits Alleviates High-Salt and Cholesterol Diet-Induced Cognitive Impairment in Rats via Nrf2–ARE Pathway I Husain, M Akhtar, T Madaan, D Vohora, MZ Abdin, M Islamuddin, ... Frontiers in pharmacology 9, 23, 2018 | 36 | 2018 |
| Appraisal of transdermal water-in-oil nanoemulgel of selegiline HCl for the effective management of Parkinson’s disease: pharmacodynamic, pharmacokinetic, and biochemical … S Setya, T Madaan, M Tariq, BK Razdan, S Talegaonkar AAPS PharmSciTech 19, 573-589, 2018 | 29 | 2018 |
| Design and development of novel transdermal nanoemulgel for Alzheimer’s disease: Pharmacokinetic, pharmacodynamic and biochemical investigations S Setya, T Madaan, BK Razdan, M Farswan, S Talegaonkar Current Drug Delivery 16 (10), 902-912, 2019 | 17 | 2019 |
| Unfolding the pleiotropic facades of rosuvastatin in therapeutic intervention of myriads of neurodegenerative disorders I Husain, S Khan, S Khan, T Madaan, S Kumar, AK Najmi Clinical and Experimental Pharmacology and Physiology 46 (4), 283-291, 2019 | 17 | 2019 |
| Exploring novel pharmacotherapeutic applications and repurposing potential of sodium glucose CoTransporter 2 inhibitors T Madaan, I Husain, M Akhtar, AK Najmi Clinical and Experimental Pharmacology and Physiology 45 (9), 897-907, 2018 | 15 | 2018 |
| Rosuvastatin alleviates high-salt and cholesterol diet-induced cognitive impairment in rats via Nrf2–ARE pathway I Husain, M Akhtar, T Madaan, MZ Abdin, M Islamuddin, AK Najmi Redox Report 23 (1), 168-179, 2018 | 15 | 2018 |
| An engineered probiotic platform for cancer epitope‐independent targeted radionuclide therapy of solid tumors NA Siddiqui, AJ Ventrola, AR Hartman, T Konare, NS Kamble, ... Advanced Healthcare Materials 12 (19), 2202870, 2023 | 13 | 2023 |
| Nanotechnology - A smart drug delivery tool in modern healthcare T Madaan, S Pandey, S Talegaonkar Journal of Chemical and Pharmaceutical Research 7 (6), 257-264, 2015 | 12 | 2015 |
| Box-behnken design of experiment assisted development and optimization of bendamustine HCl loaded hydroxyapatite nanoparticles SC Thomas, T Madaan, Z Iqbal, S Talegaonkar Current Drug Delivery 15 (9), 1230-1244, 2018 | 8 | 2018 |
| Advances in Microbiome‐Based Therapeutics for Dermatological Disorders: Current Insights and Future Directions T Madaan, K Doan, A Hartman, D Gherardini, A Ventrola, Y Zhang, ... Experimental Dermatology 33 (12), e70019, 2024 | 1 | 2024 |
| Expression and Secretion of UV Absorbent Material from Transformed Bacteria N Kotagiri, T Madaan US Patent App. 17/674,161, 2022 | | 2022 |
| Abstract P1043: Myocardial Infarction Induces Translocation Of Gut Bacteria To The Heart T Madaan, M Nieman, N Siddiqui, J Lorenz, S Sadayappan, N Kotagiri Circulation Research 131 (Suppl_1), AP1043-AP1043, 2022 | | 2022 |
Abul Kalam NajmiJamia Hamdard (Hamdard University), New Delhi, IndiaВерификована је имејл адреса на jamiahamdard.ac.in